Gland Pharma Ltd. Financials

NSE BSE

15:59 Sep 12

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2021.20

+55.40 (+2.82%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2021.20

+55.40 (+2.82%)
15:59 Sep 12

Quality

70/100
High Financial Strength

Valuation

33/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	4400.71	3624.6	5664.72	5616.5	5720.41
Operating Expenses +	2890.55	2599.83	4331.65	4347.58	4348.15
Raw Material	2072.52	1732.34	2275.2	2186.12	2076.98
Increase Decrease in Cost	36.69	-46.92	127.88	103.41	-29.71
Other Manufacturing Expense	95.05	124.84	0	0	198.3
Employee Cost	338.57	403.26	1256.89	1401.56	1454.08
Miscellaneous Expenses	399.04	417.49	717.82	685.47	648.5
Operating Profit	1510.16	1024.77	1333.07	1268.92	1372.26
Other Income	223.94	240.46	170.24	213.61	219.71
Depreciation	110.3	146.74	344.57	377.87	386.96
Interest	5.24	7.45	26.2	42	47.88
Profit before tax and exceptio..	1618.55	1111.04	1132.54	1062.66	1157.13
Exceptional Items	0	-56.46	0	0	0
PBT	1618.55	1054.58	1132.54	1062.66	1157.13
Provision for Taxation	406.89	273.54	360.08	364.13	386.91
Net Profit	1211.66	781.04	772.46	698.53	770.24
NET Profit after MI	1211.66	781.04	772.46	698.53	770.24
EPS	73.81	47.43	46.9	42.4	46.75
Operating Profit Margin (%)	34.32	28.27	23.53	22.59	23.99
Net Profit Margin (%)	27.53	21.55	13.64	12.44	13.46

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	51.80	51.80	51.80	51.80	51.80
FII	7.40	6.90	5.00	4.50	6.90
MF	30.70	31.20	32.40	32.80	30.50
Others	2.10	2.10	2.40	2.50	2.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: